1. Designs for experiments-parallel comparisons of treatment;Lavori, P.W.; Louis, T.A.; Bailar JC, III, Polansky; M.;N EnglJ Med,1983
2. er al. A randomised prospective trial of intravenous nitroglycerin in patients with acute myocardial infarction;Flaherty, J.T.; Becker, L.C.; Bulkley, B.H.;Circulation,1983
3. Human ultralente insulin. BrMedJ';Holman, R.R.; Steemson, J.; Darling, P.; Reeves, W.G.; Turner, R.C.,1984
4. Controlled trial of artificial surfactant to prevent respiratory distress syndrome;Halliday, H.L.; McClure, G.; MMcC, Reid; Lappin, T.R.J.; Meban, C.; Thomas, P.S.;Lancet,1984
5. Importance of prognostic factors in the analysis of data from clinical trials;Armitage, P.;Controlled Clinical Trials,1981